Company intelligence / Profile preview
Milla Pharmaceuticals Inc.
Minnetonka, Minnesota, United Statesmillapharmaceuticals.com ↗
- Ownership
- Private
- Employees
- ~144
- Development stage
- Commercial
01
Overview
Milla Pharmaceuticals has received multiple FDA approvals for generic drugs, including two "First Cycle" approvals. Their approved products include Pyridostigmine Bromide Syrup (generic version of Mestinon®), Sodium Acetate Injection, Dexmedetomidine Hydrochloride Injection (generic version of Precedex®), and Tromethamine Injection[4][8][9][10].
- Therapeutic areas
- Metabolic DisordersPsychiatryNeurology
- Modalities
- Generic pharmaceuticalsinjectable and solution products
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Acella Pharmaceuticals LLC
Beyond the preview
Go deeper on Milla Pharmaceuticals Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Milla Pharmaceuticals Inc..